Concepedia

Author

Jan Larmann

Medizinische Hochschule HannoverORCID

Also Known As

Anne Houben, J LARMANN, J Larmann, J. Larmann, Jan Larmann, Larmann, J., Larmann, Jan

163

Publications

2.2K

Citations

23

H-Index

65

Concepts

All Affiliations

Medizinische Hochschule HannoverHeidelberg UniversityUniversity Hospital HeidelbergUniversity Hospital MünsterHeinrich Heine University Düsseldorf
JL

About

Jan Larmann is an author at Medizinische Hochschule Hannover specializing in medicine, immunology, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

268

2

Public Health

3

3

135

3

Engineering

1

1

27

4

Natural Sciences

1

1

24

5

Biochemistry

1

1

24

Jan Larmann

×

33

Publications

1.4K

Citations

21

H-Index

YearCitations

High-Density Lipoproteins and Their Constituent, Sphingosine-1-Phosphate, Directly Protect the Heart Against Ischemia/Reperfusion Injury In Vivo via the S1P <sub>3</sub> Lysophospholipid Receptor

Gregor Theilmeier, Christoph Schmidt, Jörg Herrmann,

Circulation

2006

411

The accuracy of novel antigen rapid diagnostics for SARS-CoV-2: a living systematic review and meta-analysis

Lukas E. Brümmer, Stephan Katzenschlager, Mary Gaeddert,

2021

77

Preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with major adverse cardiovascular and cerebrovascular events in coronary heart disease patients undergoing non-cardiac surgery

Jan Larmann, Jessica Handke, Anna S. Scholz,

BMC Cardiovascular Disorders

2020

74

Perioperative Levels and Changes of High-Sensitivity Troponin T Are Associated With Cardiovascular Events in Vascular Surgery Patients*

Hans-Jörg Gillmann, Antje Meinders, Anika Grohennig,

Critical Care Medicine

2014

71

Gastrointestinal Complications After Pancreatoduodenectomy With Epidural vs Patient-Controlled Intravenous Analgesia

Rosa Klotz, Jan Larmann, Christina Klose,

JAMA Surgery

2020

70

Thrombomodulin's lectin-like domain reduces myocardial damage by interfering with HMGB1-mediated TLR2 signalling

Christine Herzog, Anika Lorenz, Hans-Jörg Gillmann,

Cardiovascular Research

2013

55

Risk assessment for major adverse cardiovascular events after noncardiac surgery using self-reported functional capacity: international prospective cohort study

Giovanna Lurati Buse, Eckhard Mauermann, Daniela Ionescu,

British Journal of Anaesthesia

2023

46

Syndecan-4 signalling inhibits apoptosis and controls NFAT activity during myocardial damage and remodelling

Frank Echtermeyer, Thomas Harendza, Svenja Hubrich,

Cardiovascular Research

2011

45

Urokinase Receptor Mediates Osteogenic Differentiation of Mesenchymal Stem Cells and Vascular Calcification via the Complement C5a Receptor

Parnian Kalbasi Anaraki, Margret Patecki, Jan Larmann,

Stem Cells and Development

2013

44

Lidocaine Protects from Myocardial Damage due to Ischemia and Reperfusion in Mice by Its Antiapoptotic Effects

Dominik J. Kaczmarek, Christine Herzog, Jan Larmann,

Anesthesiology

2009

38

Page 1